New scan for children with sarcoma
Part of Cancer clinical trials.
This trial uses a new type of scan to look at sarcomas (a kind of cancer) in children more clearly. The scan combines a special tracer and MRI to help doctors see the cancer better, which may improve diagnosis and treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 18 years old.
- You have been referred to the recruiting department because you may have a sarcoma (a type of cancer).
- You or your parents can read and understand the information sheet in Danish or English and sign a consent form.
- You are not pregnant or breastfeeding.
- You can undergo the scan without needing sedation (medicine to keep you calm or asleep).
- You do not have severe claustrophobia (fear of enclosed spaces) or other reasons that make MRI unsafe for you.
- You have not had an allergic reaction to a substance similar to the tracer used in this scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging agent, [18F]FAPI-74, which might help detect certain cancers more clearly. The scan looks for a protein called fibroblast activation protein (FAP) that is often found in tumors. If you have one of the listed cancers and are about to start treatment, this study could help doctors see where the cancer is and how it responds to therapy.
This study tests a new type of PET scan (a detailed imaging test) called [68Ga]Ga-FAPI that may help doctors see cancer better and faster than standard scans. You'll receive this experimental scan to see if it improves cancer detection before surgery.
This trial tests a new type of PET scan that may find cancer more clearly and quickly than current scans. It's for people with advanced melanoma that has spread and cannot be removed by surgery.
This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.
This trial tests a special PET/CT scan using a new tracer (68Ga-FAPI) to help show tumors in the pancreas, bile ducts, stomach, or certain ovarian cancers. It may help doctors better see where cancer is in preparation for surgery or biopsy.
This study uses a new imaging agent called [68Ga]-FAPI-JNU to take detailed pictures of tumors with a PET/CT scan. It aims to see how well this tracer works in people with various types of cancer.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.